Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Viral Vector Vaccines bulk supplier for pharma manufacturers

Viral Vector Vaccines 0.5 mL Suppliers & Bulk Manufacturers

Available Forms: Intramuscular injectable suspension (IM)

Available Strengths: 0.5 mL

Reference Brands: Jcovden (US)

Category: Vaccines

Viral vector vaccines, a platform using adenovirus and other modified viruses to deliver antigen genes, given as 0.5 mL intramuscular doses. For ministries of health, UN-agency buyers, licensed importers and hospitals.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Viral Vector Vaccines? List it or send an offer →

Product Description:

Viral vector vaccines use a modified virus to carry a gene for a target antigen into the body's cells, which then make the antigen and present it to the immune system, producing both antibody and T-cell responses. Most vectors in use are replication-deficient adenoviruses of human or chimpanzee origin; others include modified vaccinia Ankara and a replication-competent vesicular stomatitis virus carrying a foreign surface protein. This is a platform listing: products are typically 0.5 mL intramuscular doses of suspension, but each vaccine has its own composition and label.

The platform has been used for vaccines against Ebola virus disease and COVID-19, among others. Schedules differ: some products use one dose, others two, and some pair different vectors to sidestep immunity against the first. Pre-existing immunity to common human adenoviruses can blunt the response, so non-human and rare vectors are used. Regulators have added rare but serious adverse events to some adenovirus-vector labels, including thrombosis with thrombocytopenia syndrome, so current product information and national guidance govern use.

Sourcing notes. Vaccines are bought through national immunisation programmes, UN agencies or licensed importers, and each lot normally needs release by the national regulatory authority or control laboratory, based on the manufacturer's summary lot protocol. WHO prequalification, or Emergency Use Listing in emergencies, opens the way to UN-agency supply and supports national approval. Storage ranges from 2 to 8 °C to frozen or ultra-cold, so match your cold chain to the label. Request the CoA, lot release certificate and GMP certificate, and specify product, presentation and quantities.

Viral Vector Vaccines — third party manufacturing & bulk supply

Viral Vector Vaccines 0.5 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Viral Vector Vaccines is supplied as Intramuscular injectable suspension (IM) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Viral Vector Vaccines listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Viral Vector Vaccines →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Viral Vector Vaccines is listed as Intramuscular injectable suspension (IM) in 0.5 mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Viral Vector Vaccines is referenced against Jcovden (US). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

mRNA-Based Vaccines

Strength:
30 µg and 100 µg

Form: Injectable suspension

Reference Brands: Comirnaty, Spikevax(US)

View Details
Inactivated Vaccines

Strength:
Dose and concentration depend on formulations

Form: Injectable suspension (IM administration), Lyophilized powder for reconstitution

Reference Brands: -

View Details
Meningococcal Vaccine

Strength:
0.5 mL

Form: Vial or pre-filled syringe (injectable), Conjugate vaccines

Reference Brands: Menactra, Menveo (US)

View Details
Cholera Vaccine

Strength:
2.0 mL

Form: Oral live attenuated vaccine (liquid suspension), Inactivated killed vaccine (injectable)

Reference Brands: Dukoral (USA)

View Details
Pneumococcal Vaccine

Strength:
23-valent, 25 mcg of each polysaccharide per 0.5 mL dose

Form: Injection

Reference Brands:

View Details
Haemophilus TYPE B Conjugate Vaccine

Strength:
10 mcg+ 25mcg, 7.5 mcg + 125 mcg

Form: Injection

Reference Brands: ActHIB (USA), Hiberix (USA)

View Details
Yellow Fever Vaccine

Strength:
0.5 mL per dose

Form: Injection

Reference Brands:

View Details
Docaravimab, Miromavimab

Strength:
600IU

Form: Injection

Reference Brands: TWINRAB

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us